Social and emotional impact of diabetic retinopathy: A review

Clinical and Experimental Ophthalmology

Volumn 40, Issue 1, 2012, Pages 27-38

  Fenwick, Eva ^a   Rees, Gwyn ^a   Pesudovs, Konrad ^b   Dirani, Mohamed ^a   Kawasaki, Ryo ^a   Wong, Tien Y ^a,c   Lamoureux, Ecosse ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

Author keywords

Diabetic retinopathy; Distress; Emotional well being; Impact; Social well being

Indexed keywords

ANGER; ANXIETY; COMMUNITY; COPING BEHAVIOR; DEPRESSION; DETERIORATION; DIABETIC RETINOPATHY; EMBASE; EMOTION; FAMILY; FAMILY FUNCTIONING; FAMILY RELATION; FEAR; FINANCIAL MANAGEMENT; FRUSTRATION; GUILT; HELPLESSNESS; HUMAN; HUMAN RELATION; INCOME; LEISURE; MEDLINE; MENTAL DISEASE; OUTCOME ASSESSMENT; PRODUCTIVITY; QUESTIONNAIRE; REVIEW; SELF CONCEPT; SELF ESTEEM; SOCIAL ASPECT; SOCIAL INTERACTION; SOCIAL ISOLATION; SOCIAL LIFE; STRESS; SYSTEMATIC REVIEW; UNCERTAINTY; VISUAL IMPAIRMENT; WELLBEING; WORK;

AFFECTIVE SYMPTOMS; DIABETIC RETINOPATHY; HUMANS; SOCIAL PROBLEMS; STRESS, PSYCHOLOGICAL;

EID: 79961204987     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2011.02599.x     Document Type: Review

References (65)

1. Cheung N, Wong T. Diabetic retinopathy and systemic complications. In: Duh E, ed. Diabetic Retinopathy. New Jersey: Humana Press, 2009; 465-82.
2. Wong T, Klein K. The epidemiology of eye diseases in diabetes. In: Ekoé J, Rewers M, Williams R etal., eds. The Epidemiology of Diabetes Mellitus, 2nd edn. Oxford: John Wiley and Sons, 2008; 475-97.
3. Cheung N, Mitchell P, Wong T. Diabetic retinopathy. Lancet 2010; 376: 124-36.
4. Frank RN. Diabetic retinopathy. N Engl J Med 2004; 350: 48-58.
5. Gavard JA, Lustman PJ, Clouse RE. Prevalence of depression in adults with diabetes - an epidemiologic evaluation. Diabetes Care 1993; 16: 1167-78.
6. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes - a meta-analysis. Diabetes Care 2001; 24: 1069-78.
7. Evans JR, Fletcher AE, Wormald RPL. Depression and anxiety in visually impaired older people. Ophthalmology 2007; 114: 283-8.
8. Horowitz A. The prevalence and consequences of vision impairment in later life. Top Geriatr Rehabil 2004; 20: 185-95.
9. Nyman SR, Gosney MA, Victor CR. Psychosocial impact of visual impairment in working-age adults. Br J Ophthalmol 2010; 94: 1427-31.
10. Golden SH, Lazo M, Carnethon M etal. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008; 299: 2751-9.
11. Rovner BW, Ganguli M. Depression and disability associated with impaired vision: the MoVies Project. J Am Geriatr Soc 1998; 46: 617-19.
12. Rovner BW, Casten RJ, Tasman WS. Effect of depression on vision function in age-related macular degeneration. Arch Ophthalmol 2002; 120: 1041-4.
13. Brody BL, Gamst AC, Williams RA etal. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology 2001; 108: 1893-900; discussion 900-1.
14. Katon WJ, Rutter C, Simon G etal. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005; 28: 2668-72.
15. Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 2003; 26: 2822-8.
16. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes - impact of depression symptoms on adherence, function, costs. Arch Intern Med 2000; 160: 3278-85.
17. Egede LE. Diabetes, major depression, and functional disability among US adults. Diabetes Care 2004; 27: 421-8.
18. Lee HJ, Chapa D, Kao CW etal. Depression, quality of life, and glycemic control in individuals with type 2 diabetes. J Am Acad Nurse Pract 2009; 21: 214-24.
19. Cohen ST, Welch G, Jacobson AM, De Groot M, Samson J. The association of lifetime psychiatric illness and increased retinopathy in patients with type 1 diabetes mellitus. Psychosomatics 1997; 38: 98-108.
20. Roy MS, Roy A, Affouf M. Depression is a risk factor for poor glycemic control and retinopathy in African-Americans with type 1 diabetes. Psychosom Med 2007; 69: 537-42.
21. Nguyen TT, Wong TY, Islam FM etal. Evidence of early retinal microvascular changes in patients with type 2 diabetes and depression. Psychosom Med 2010; 72: 1-4.
22. Fisher L, Skaff MM, Mullan JT etal. Clinical depression versus distress among patients with type 2 diabetes - not just a question of semantics. Diabetes Care 2007; 30: 542-8.
23. Fenwick E, Rees G, Dirani M etal. The impact of the severity of diabetic retinopathy: understanding the patient's perspective. Br J Ophthalmol 2011; 95: 774-82.
24. Bernbaum M, Albert SG, Duckro PN, Merkel W. Personal and family stress in individuals with diabetes and vision loss. J Clin Psychol 1993; 49: 670-7.
25. Candrilli SD, Davis KL, Kan HJ, Lucero MA, Rousculp MD. Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy. J Diabetes Complications 2007; 21: 306-14.
26. Coyne KS, Margolis MK, Kennedy-Martin T etal. The impact of diabetic retinopathy: perspectives from patient focus groups. Fam Pract 2004; 21: 447-53.
27. Devenney R, O'Neill S. The experience of diabetic retinopathy: a qualitative study. Br J Health Psychol 2011; 16: 707-72.
28. Klein R, Klein BEK, Moss SE. Epidemiology of proliferative diabetic-retinopathy. Diabetes Care 1992; 15: 1875-91.
29. Klein R, Klein BEK, Jensen SC, Moss SE. The relation of socioeconomic-factors to the incidence of proliferative diabetic-retinopathy and loss of vision. Ophthalmology 1994; 101: 68-76.
30. Oehlergiarratana J, Fitzgerald RG. Group-therapy with blind diabetics. Arch Gen Psychiatry 1980; 37: 463-7.
31. Woodcock A, Bradley C, Plowright R, Ffytche T, Kennedy-Martin T, Hirsch A. The influence of diabetic retinopathy on quality of life Interviews to guide the design of a condition-specific, individualised questionnaire: the RetDQoL. Patient Educ Couns 2004; 53: 365-83.
32. Bernbaum M, Albert SG, Duckro PN. Psychosocial profiles in patients with visual impairment due to diabetic-retinopathy. Diabetes Care 1988; 11: 551-7.
33. Cox DJ, Kiernan BD, Schroeder DB, Cowley M. Psychosocial sequelae of visual loss in diabetes. Diabetes Educ 1998; 24: 481-4.
34. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001; 63: 619-30.
35. Jacobson AM, Rand LI, Hauser ST. Psychologic stress and glycemic control - a comparison of patients with and without proliferative diabetic retinopathy. Psychosom Med 1985; 47: 372-81.
36. Luckie R, Leese G, McAlpine R etal. Fear of visual loss in patients with diabetes: results of the Prevalence of Diabetic Eye Disease in Tayside, Scotland (P-DETS) study. Diabet Med 2007; 24: 1086-92.
37. Robertson N, Burden ML, Burden AC. Psychological morbidity and problems of daily living in people with visual loss and diabetes: do they differ from people without diabetes? Diabet Med 2006; 23: 1110-16.
38. Scanlon PH, Martin ML, Bailey C, Johnson E, Hykin P, Keightley S. Reported symptoms and quality-of-life impacts in patients having laser treatment for sight-threatening diabetic retinopathy. Diabet Med 2006; 23: 60-6.
39. Trento M, Tomelini M, Lattanzio R etal. Perception of, and anxiety levels induced by, laser treatment in patients with sight-threatening diabetic retinopathy. A multicentre study. Diabet Med 2006; 23: 1106-9.
40. Wulsin LR, Jacobson AM, Rand LI. Psychosocial-aspects of diabetic-retinopathy. Diabetes Care 1987; 10: 367-73.
41. Wulsin LR, Jacobson AM, Rand LI. Psychosocial adjustment to advanced proliferative diabetic-retinopathy. Diabetes Care 1993; 16: 1061-6.
42. Broman AT, Munoz B, Rodriguez J etal. The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER. Invest Ophthalmol Vis Sci 2002; 43: 3393-8.
43. Gabrielian A, Hariprasad S, Jager R, Green J, Mieler W. The utility of visual function questionnaire in the assessment of the impact of diabetic retinopathy on vision-related quality of life. Eye 2010; 24: 29-35.
44. Hariprasad SM, Mieler WF, Grassi M, Green JL, Jager RD, Miller L. Vision-related quality of life in patients with diabetic macular oedema. Br J Ophthalmol 2008; 92: 89-92.
45. Hirai FE, Tielsch JM, Klein BE, Klein R. Ten-year change in vision-related quality of life in type 1 diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 2010; 118: 353-8.
46. Klein R, Moss SE, Klein BEK, Gutierrez P, Mangione CM. The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus - The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol 2001; 119: 733-40.
47. Lamoureux EL, Hassell JB, Keeffe JE. The impact of diabetic retinopathy on participation in daily living. Arch Ophthalmol 2004; 122: 84-8.
48. Matza LS, Rousculp MD, Malley K, Boye KS, Oglesby A. The longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy. Health Qual Life Outcomes 2008; 6: 95.
49. Mazhar K, Varma R, Choudhury F, McKean-Cowdin R, Shtir CJ, Azen SP. Severity of diabetic retinopathy and health-related quality of life The Los Angeles Latino Eye Study. Ophthalmology 2010; 116: 1496-504.
50. Fisher L, Skaff MM, Mullan JT, Arean P, Glasgow R, Masharani U. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with Type 2 diabetes. Diabet Med 2008; 25: 1096-101.
51. Fisher L, Mullan JT, Skaff MM, Glasgow RE, Arean P, Hessler D. Predicting diabetes distress in patients with Type 2 diabetes: a longitudinal study. Diabet Med 2009; 26: 622-7.
52. Polonsky WH, Fisher L, Earles J etal. Assessing psychosocial distress in diabetes - Development of the Diabetes Distress Scale. Diabetes Care 2005; 28: 626-31.
53. Fisher L, Mullan JT, Arean P, Glasgow RE, Hessler D, Masharani U. Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care 2010; 33: 23-8.
54. Marella M, Pesudovs K, Keeffe J, O'Connor PM, Rees G, Lamoureux EL. The psychometric validity of the NEI VFQ-25 for use in a low vision population. Invest Ophthalmol Vis Sci 2010; 51: 2878-84.
55. Pesudovs K, Gothwal V, Wright T, Lamoureux E. Remediating serious flaws in the National Eye Institute-Visual Function Questionnaire. J Cataract Refract Surg 2010; 36: 718-32.
56. Pesudovs K, Burr JM, Harley C, Elliott DB. The development, assessment, and selection of questionnaires. Optom Vis Sci 2007; 84: 663-74.
57. Pesudovs K, Garamendi E, Keeves JP, Elliott DB. The Activities of Daily Vision Scale for cataract surgery outcomes: re-evaluating validity with Rasch analysis. Invest Ophthalmol Vis Sci 2003; 44: 2892-9.
58. Vanalphen A, Halfens R, Hasman A, Imbos T. Likert or Rasch - nothing is more applicable than good theory. J Adv Nurs 1994; 20: 196-201.
59. Massof RW. Likert and Guttman scaling of visual function rating scale questionnaires. Ophthalmic Epidemiol 2004; 11: 381-99.
60. Massof RW. The measurement of vision disability. Optom Vis Sci 2002; 79: 516-52.
61. Gershon RC. Computer adaptive testing. J Appl Meas 2005; 6: 109-27.
62. Pesudovs K. Item banking: a generational change in patient-reported outcome measurement. Optom Vis Sci 2010; 87: 1-9.
63. Revicki DA, Cella DF. Health status assessment for the twenty-first century: item response theory, item banking and computer adaptive testing. Qual Life Res 1997; 6: 595-600.
64. Cella D, Gershon R, Lai JS, Choi S. The future of outcomes measurement: item banking, tailored short-forms, and computerized adaptive assessment. Qual Life Res 2007; 16 (Suppl. 1): 133-41.
65. Lamoureux E, Pesudovs K. Vision-specific quality-of-life research: a need to improve the quality. Am J Ophthalmol 2011; 151: 195-7 e2.